TAT-cyclo-CLLFVY TFA is a cyclic peptide inhibitor specifically targeting HIF-1 heterodimerization to mitigate hypoxia signaling within cancer cells. It effectively disrupts the protein-protein interaction between HIF-1alpha and HIF-1beta, demonstrating an inhi
Molecular Weight:
2673.1
Formula:
C113H189F3N42O26S2
* VAT and and shipping costs not included. Errors and price changes excepted
